1
The Comparison of the Pharmacokinetic, Safety and Tolerability of Alpha-1 MP and Prolastin In Adult Alpha1-Antitrypsin Deficient Patients
Condition(s): Alpha 1-Antitrypsin Deficiency Last Updated: September 26, 2008Completed
67 Clinical Trials for: Alpha 1-Antitrypsin, Page 1 of 4
Hide Studies Not Seeking New Volunteers
2
Effect of Double Dose of Alpha 1-antitrypsin Augmentation Therapy on Lung Inflammation.
Condition(s): Alpha 1 Antitrypsin Deficiency Last Updated: February 26, 2013Recruiting
3
Efficacy and Safety Study of Augmentation Therapy With ARALAST Fraction IV-1 (Human Alpha 1 - Proteinase Inhibitor)
Condition(s): Alpha 1-Antitrypsin Deficiency Last Updated: March 3, 2011Completed
4
Alpha-1-Antitrypsin (AAT) To Treat Emphysema In AAT-Deficient Patients (EXACTLE)
Condition(s): Alpha 1-Antitrypsin Deficiency Last Updated: August 7, 2009Completed
5
Pharmacokinetic Study of ARALAST (Human Alpha1- PI)
Condition(s): Alpha 1-Antitrypsin Deficiency Last Updated: July 18, 2011Completed
6
Safety and Pharmacokinetics of Alpha-1 Proteinase Inhibitor in Subjects With Alpha1-Antitrypsin Deficiency
Condition(s): Emphysema; Alpha 1-antitrypsin Deficiency (AATD) Last Updated: July 27, 2012Completed
7
Extension Study of Zemaira i.v. Administration in Subjects With Emphysema Due to alpha1-proteinase Inhibitor Deficiency.
Condition(s): Emphysema; Alpha 1-proteinase Inhibitor Deficiency Last Updated: May 15, 2013Active, not recruiting
8
Aralast alpha1-proteinase Inhibitor Surveillance Study
Condition(s): Alpha 1-Antitrypsin (AAT) Deficiency Last Updated: August 23, 2011Terminated
9
Therapy to Elevate CD4 Counts in HIV-1 Disease
Condition(s): HIV Disease Last Updated: June 8, 2011Completed
10
The Effects of Alpha-1 Antitrypsin (AAT) on the Progression of Type 1 Diabetes
Condition(s): Diabetes; Type 1 Diabetes Last Updated: January 7, 2013Recruiting
11
Safety Study of an Aerosolized, Recombinant Alpha 1-Antitrypsin in Subjects With Alpha 1-Antitrypsin Deficiency
Condition(s): Alpha 1-Antitrypsin Deficiency Last Updated: October 18, 2006Completed
12
Zemaira in Subjects With Emphysema Due to Alpha1-Proteinase Inhibitor (API) Deficiency
Condition(s): Alpha1-proteinase Inhibitor Deficiency; Emphysema Last Updated: November 1, 2012Completed
13
A Research Trial of Aralast in New Onset Diabetes (RETAIN) - Part II
Condition(s): Diabetes Mellitus, Type 1 Last Updated: August 16, 2010Not yet recruiting
14
A Research Trial of Aralast in New Onset Diabetes (RETAIN) - Part I
Condition(s): Diabetes Mellitus, Type 1 Last Updated: November 8, 2012Active, not recruiting
15
The Safety and Tolerability of Alpha-1 MP In Subjects With Alpha-1-Antitrypsin (AAT) Deficiency
Condition(s): Alpha 1-Antitrypsin Deficiency Last Updated: September 26, 2008Completed
16
Study of the Effect of Aerosolized, Recombinant Alpha 1-Antitrypsin on Epithelial Lining Fluid Analytes in Subjects With Alpha 1-Antitrypsin Deficiency
Condition(s): Alpha 1-Antitrypsin Deficiency Last Updated: October 18, 2006Completed
17
Safety & Efficacy Study of rAAV1-CB-hAAT for Alpha-1 Antitrypsin Deficiency
Condition(s): Alpha-1 Antitrypsin Deficiency Last Updated: March 6, 2013Active, not recruiting
18
GLASSIA Infusion Rate Study
Condition(s): Alpha1-antitrypsin Deficiency; Healthy Last Updated: January 26, 2013Completed
19
Alpha 1 Anti-Trypsin in Treating Patients With Acute Graft-Versus-Host Disease
Condition(s): Graft Versus Host Disease Last Updated: December 17, 2012Withdrawn
20
International Study Evaluating the Safety and Efficacy of Inhaled, Human, Alpha-1 Antitrypsin (AAT) in Alpha-1 Antitrypsin Deficient Patients With Emphysema
Condition(s): Emphysema Last Updated: February 18, 2013Active, not recruiting
